Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01220440Phase 4Completed
A Phase 4 trial of methylphenidate, dextroamphetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Ostfold Hospital Trust. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01220440.